Immunoblotting results consistently demonstrated that DM-AKG treatment significantly prevented the reduction of MFN1 (p < 0.01) and the increase of DRP1 expression (p < 0.001) in the kidney tissues of CIS-AKI mice (Fig. 6a). Here, MFN1 is linked to in situ carcinoma.